$588 Million is the total value of CADINHA & CO LLC's 94 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 4.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABBV | Abbvie Inc | $1,937,000 | +28.9% | 19,725 | 0.0% | 0.33% | -17.5% | |
XLY | Select Sector SPDR Cons Discreetf-eq | $1,724,000 | +30.2% | 13,500 | 0.0% | 0.29% | -16.8% | |
ABT | Abbott Laboratories | $1,723,000 | +15.9% | 18,843 | 0.0% | 0.29% | -25.8% | |
LLY | Eli Lilly & Co | $1,338,000 | +18.3% | 8,150 | 0.0% | 0.23% | -24.0% | |
PFE | Pfizer Inc | $1,162,000 | +0.2% | 35,547 | 0.0% | 0.20% | -35.7% | |
BRKA | Berkshire Hathaway Inc Cl A | $1,069,000 | -1.7% | 4 | 0.0% | 0.18% | -37.0% | |
IVE | iShares S&P 500 Valueetf-eq | $823,000 | +12.4% | 7,608 | 0.0% | 0.14% | -27.8% | |
WFC | Wells Fargo & Co | $767,000 | -10.8% | 29,972 | 0.0% | 0.13% | -43.0% | |
PEP | PepsiCo Inc | $639,000 | +10.2% | 4,832 | 0.0% | 0.11% | -29.2% | |
GOOG | Alphabet Inc Cap Stock Cl C | $417,000 | +21.6% | 295 | 0.0% | 0.07% | -22.0% | |
TXN | Texas Instruments Inc | $406,000 | +26.9% | 3,200 | 0.0% | 0.07% | -18.8% | |
VIG | Vanguard Div Apprec ETFetf-eq | $407,000 | +13.4% | 3,471 | 0.0% | 0.07% | -27.4% | |
NSC | Norfolk Southern Corp | $392,000 | +20.2% | 2,235 | 0.0% | 0.07% | -23.0% | |
DD | DuPont de Nemours Inc | $375,000 | +55.6% | 7,054 | 0.0% | 0.06% | 0.0% | |
DOW | Dow Inc | $349,000 | +39.6% | 8,554 | 0.0% | 0.06% | -10.6% | |
CSX | CSX Corp | $342,000 | +21.7% | 4,900 | 0.0% | 0.06% | -22.7% | |
TLH | iShares Barclays 10-20 Yearsetf-fi | $321,000 | 0.0% | 1,918 | 0.0% | 0.06% | -35.3% | |
CL | Colgate Palmolive Co | $274,000 | +10.5% | 3,737 | 0.0% | 0.05% | -28.8% | |
HSY | Hershey Co | $259,000 | -2.3% | 2,000 | 0.0% | 0.04% | -37.1% | |
DUK | Duke Energy Corp | $254,000 | -1.2% | 3,177 | 0.0% | 0.04% | -36.8% | |
IFF | International Flavors & Fragra | $245,000 | +20.1% | 2,000 | 0.0% | 0.04% | -22.2% | |
KIQ | Kelso Technologies Inc | $7,000 | +16.7% | 11,400 | 0.0% | 0.00% | -50.0% | |
MRPI | Mera Pharmaceuticals Inc | $1,000 | – | 657,943 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-22
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Berkshire Hathaway Inc Cl B | 42 | Q3 2023 | 9.3% |
Costco Wholesale Corp | 42 | Q3 2023 | 8.6% |
Johnson & Johnson | 42 | Q3 2023 | 6.1% |
Home Depot Inc | 42 | Q3 2023 | 5.5% |
Apple Inc | 42 | Q3 2023 | 8.7% |
Danaher Corp | 42 | Q3 2023 | 6.1% |
Microsoft Corp | 42 | Q3 2023 | 7.3% |
Exxon Mobil Corp | 42 | Q3 2023 | 6.3% |
Accenture PLC Ireland Class A | 42 | Q3 2023 | 5.3% |
Merck & Co Inc | 42 | Q3 2023 | 6.0% |
View CADINHA & CO LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
KELSO TECHNOLOGIES INC | February 14, 2017 | 1,861,680 | 4.0% |
View CADINHA & CO LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-02 |
13F-HR | 2024-01-24 |
13F-HR | 2023-11-02 |
13F-HR | 2023-07-26 |
13F-HR | 2023-04-28 |
13F-HR | 2023-01-25 |
13F-HR | 2022-10-21 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-03 |
View CADINHA & CO LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.